Recombinant Human COL18A1 protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
C-His
Activity
not tested
Cat no : Eg0254
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human COL18A1 protein His1572-Lys1754 (Accession# P39060-3) with a His tag at the C-terminus. |
GeneID | 80781 |
Accession | P39060-3 |
PredictedSize | 23.9 kDa |
SDS-PAGE | 25-28 kDa, reducing (R) condition |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Endostatin, a 20-kDa C-terminal fragment derived from collagen alpha-1(XVIII) chain (COL18A1), is an endogenously produced inhibitor of angiogenesis. Many different proteases are able to cleave the NC1 domain of collagen alpha-1(XVIII) chain to produce endostatin including cathepsins L, B, and K, elastase. Endostatin inhibits proliferation and migration of endothelial cells, angiogenesis, and tumor growth. It may interfere with the pro-angiogenic action of growth factors such as basic fibroblast growth factor (bFGF/FGF-2) and vascular endothelial growth factor (VEGF).
References:
1. M S O'Reilly, et al. (1997) Cell. 88(2):277-85 2. M Ferreras, et al. (2000) FEBS Lett. 486(3):247-51. 3. Judah Folkman. (2006) Exp Cell Res. 312(5):594-607. 4. Amit Walia, et al. (2015) Biochim Biophys Acta. 1850(12):2422-38.